AGP Executive Report
Last update: 4 hours agoHealth Funding: P.E.I. ministers say a one-year extension of federal support for mental health, addictions and home care is not enough. They want Ottawa to maintain five per cent annual growth in health transfers, rather than let the minimum fall to three per cent in 2028. Public Health: Health Canada reports dangerous bacteria in more than 11,000 seized vials of unauthorized peptides sold online. The agency also approved Moderna’s flu and flu-COVID vaccines, while a federal advisory committee recommends hepatitis B vaccination for all infants. Digital Health: Researchers warn proposed privacy legislation could let companies use sensitive health data without consent under a “legitimate interest” exception, as Ottawa advances its AI strategy. Biotech: Canadian firm Edesa licensed Japan rights to its ARDS drug candidate in a deal worth up to US$146 million plus royalties. Montreal-linked Epitopea has dosed the first patient in a UK trial of its ovarian cancer vaccine.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
